Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Gagne

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesTimothy N Hoang, Elise G Viox, Amit A Upadhyay, et al.
Science Immunology|July 28, 2023
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesElise G Viox, Timothy N Hoang, Amit A Upadhyay, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle VaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Iscience|April 20, 2026
Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testingBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesTimothy N Hoang, Elise G Viox, Amit A Upadhyay, et al.
Science Immunology|July 28, 2023
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesElise G Viox, Timothy N Hoang, Amit A Upadhyay, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeysKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle VaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 6